Drug developers looking to bring their therapies into human clinical testing in the United States are required to
file an Investigational New Drug Application (IND) with the United States Food & Drug Administration (FDA). Let us
explore the purpose of the IND, their types, the format, what the FDA really cares about, and how the applications are
approved by the FDA.